CClinicalTrials.gg
CompletedNCT05653362Updated Jun 2, 2023Results posted

Coconut Oil vs. Commercial Ultrasound Gel In Obstetric Ultrasounds

An interventional study of Coconut Oil and Commercial Ultrasound Gel in Pregnancy, High Risk, sponsored by Indiana University. Completed at 1 site in United States. Open to female participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-02.

Sponsored by Indiana University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Dec 2021, registered Nov 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Female
01

Study summary

The goal of this randomized controlled trial is to compare the use of coconut oil with commercial ultrasound gel for obstetrical ultrasounds. The main questions it aims to answer are:

  1. To evaluate the quality of ultrasound images obtained using coconut oil compared with commercial ultrasound gel.
  2. To access patient acceptability of coconut oil as compared to commercial ultrasound gel.

Participants will:

  1. Allow a total of 6 study images to be obtained; 3 using coconut oil and 3 with commercial ultrasound gel.
  2. Fill out a 10-question, 5-point Likert scale survey following their ultrasound with both coupling mediums to compare acceptability.
Read the detailed description

After receiving institutional review board approval, we conducted a randomized 2x2 crossover study. Patients could be enrolled in the study if they had a singleton pregnancy and were presenting for a routine growth or anatomy ultrasound. Exclusion criteria included an allergy to coconut, active inflammatory dermatologic conditions, and a multiple gestation pregnancy. A single ultrasound machine (GE Voluson E10) was used to obtain all images during this study. The three standard fetal biometry views - biparietal diameter (BPD)/head circumference (HC), abdominal circumference (AC), and femur length (FL) - were obtained by qualified ultrasound technicians for each patient with both coupling agents, for a total of six study images per patient. After obtaining written consent, study data were collected and managed using REDCap electronic data capture tools. REDCap (Research Electronic Data Capture) is a secure, web-based application designed to support data capture for research studies, providing: 1) an intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for importing data from external sources.

Patients were randomized to either starting their scheduled ultrasound exam by obtaining the three study images using coconut oil and then proceeding with the standard ultrasound using commercial ultrasound gel or vice versa. A total of 15g of room-temperature, organic, refined coconut oil was used for each patient. The commercial ultrasound gel used for this study was room-temperature Aquasonic 100 (Parker Laboratories, Inc., Fairfield, NJ) of an unmeasured amount. The patient's abdomen was cleaned off with a towel between applications of each coupling agent. After completion of the ultrasound session, patient satisfaction with both coupling agents was assessed using a ten-question acceptability survey measured on a five-point Likert scale which was adapted from a previously validated survey.

Using a quantifiable scale developed for this study (0-25: unacceptable, 26-50: suboptimal, 51-75: acceptable, and 76-100: optimal), two experienced Maternal-Fetal Medicine physicians rated all study images on quality, resolution, and detail as defined by prior studies2. Quality was defined as an overall assessment of the image encompassing contrast of solid and fluid-filled structures. Resolution was defined as the sharpness and crispness of the image as well as a lack of haziness/blurriness. Detail was defined as the clarity of landmarks and ease with which boundaries of structures are seen and how well they are defined. Using Viewpoint (GE Healthcare), an ultrasound viewing software, the six study images for each patient were presented in the order of coupling agent each patient was randomized to first and second. Each set of three images per coupling agent was in the following order: BPD/HC, AC, and FL. The physicians rating the images were blinded to the agent used to capture each image and had no knowledge of the randomization list created by the study statisticians.

02

Conditions studied

  • Pregnancy, High Risk

Keywords

  • ultrasonography
  • coconut oil
  • ultrasound gel
03

In context

Lead sponsor

Indiana University is the lead sponsor of 958 studies on the registry; 200 are open to participants now.

Of its 142 completed or terminated interventional studies of FDA-regulated products, 112 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Singleton pregnancy
  • Patients presenting for an anatomy or growth US
  • Patients assigned to the pre-determined ultrasound suite that will stay constant throughout the study so that the same ultrasound machine is used to obtain all images.

Exclusion criteria

Exclusion Criteria:

  • Allergy to coconut
  • Active inflammatory dermatologic conditions (dermatitis, eczema, or psoriasis)
  • Multiple gestation pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Care provider)
Enrollment
40 participants (actual)

Study arms

  • Other
    Coconut Oil followed by Commercial Ultrasound Gel

    After the patient is consented and all questions are answered, the patient's information will be entered into a RedCap and they will be randomized to either starting the scan by first obtaining the required study images with coconut oil and then proceeding to the standard ultrasound using commercial ultrasound gel (Arm 1) or to starting with the scheduled ultrasound using the commercial ultrasound gel and ending by obtaining the required study images using coconut oil (Arm 2). Whether assigned to Arm 1 or Arm 2, prior to the collection of the study images using coconut oil, the participant will be handed a small plastic cup with a pre-measured amount of coconut oil and they will be asked to warm it in their hand for at least 2 minutes. They will then apply the coconut oil to their own abdomen with their hands prior to the ultrasound technician obtaining the required images. The ultrasound technician will collect 3 extra images for study purposes only using the coconut oil.

    Device: Coconut Oil · Device: Commercial Ultrasound Gel

  • Other
    Commercial Ultrasound Gel followed by Coconut Oil

    After the patient is consented and all questions are answered, the patient's information will be entered into a RedCap and they will be randomized to either starting the scan by first obtaining the required study images with coconut oil and then proceeding to the standard ultrasound using commercial ultrasound gel (Arm 1) or to starting with the scheduled ultrasound using the commercial ultrasound gel and ending by obtaining the required study images using coconut oil (Arm 2). Whether assigned to Arm 1 or Arm 2, prior to the collection of the study images using coconut oil, the participant will be handed a small plastic cup with a pre-measured amount of coconut oil and they will be asked to warm it in their hand for at least 2 minutes. They will then apply the coconut oil to their own abdomen with their hands prior to the ultrasound technician obtaining the required images. The ultrasound technician will collect 3 extra images for study purposes only using the coconut oil.

    Device: Coconut Oil · Device: Commercial Ultrasound Gel

Interventions

  • DeviceCoconut Oil

    Coconut oil was applied to the patients' abdomen during the ultrasound to serve as a conducting medium. When applied topically, coconut oil is not absorbed systemically by the subject and will not affect the fetus. There are no studies showing a potential risk of the use of topical coconut oil in pregnancy. Subjects with a coconut allergy will be excluded from this study due to risk of allergic reaction.

  • DeviceCommercial Ultrasound Gel

    Room-temperature Aquasonic 100 (Parker Laboratories, Inc., Fairfield, NJ) applied to patients' abdomen during the ultrasound to serve an another conducting medium.

06

What researchers measure

Primary outcomes

  1. Quality of Ultrasound Images

    The quality of ultrasound images obtained using coconut oil compared with commercial ultrasound gel was assessed using a quantifiable scale developed for this study (0-25: unacceptable, 26-50: suboptimal, 51-75: acceptable, and 76-100: optimal). Using Viewpoint (GE Healthcare), an ultrasound viewing software, the six study images for each patient were presented in the order of coupling agent each patient was randomized to first and second. Each set of three images per coupling agent was in the following order: Biparietal Diameter/Head circumference (BPD/HC), abdominal circumference (AC), and femur length (FL). The physicians rating the images were blinded to the agent used to capture each image and had no knowledge of the randomization list created by the study statisticians. The image quality scores given by the two experienced Maternal-Fetal Medicine physicians were averaged to compute a single score for each image per coupling agent.

    Time frame: ultrasound scanning, an average of 1 hour

Secondary outcomes

  1. Acceptability

    Patient acceptability of coconut oil as compared to commercial ultrasound gel was assessed using a ten-question acceptability survey measured on a five-point Likert scale which was adapted from a previously validated survey. Higher scores meant a better outcome for questions 1 and 2 and a lower score meant a better outcome for questions 3, 4, and 5. The minimum value was a score of 1 and the maximum value was a score of 5.

    Time frame: after ultrasound scanning, an average of 1 hour

07

Results

Posted Jun 2, 2023
Limitations and caveats
Technicians and patients were not blinded. This study was performed at a single site.

Participant flow

Participant flow — Overall Study
MilestoneCoconut Oil Followed by Commercial Ultrasound GelCommercial Ultrasound Gel Followed by Coconut Oil
Started2020
Completed2020
Not completed00

Outcome measures

PrimaryQuality of Ultrasound Images

The quality of ultrasound images obtained using coconut oil compared with commercial ultrasound gel was assessed using a quantifiable scale developed for this study (0-25: unacceptable, 26-50: suboptimal, 51-75: acceptable, and 76-100: optimal). Using Viewpoint (GE Healthcare), an ultrasound viewing software, the six study images for each patient were presented in the order of coupling agent each patient was randomized to first and second. Each set of three images per coupling agent was in the following order: Biparietal Diameter/Head circumference (BPD/HC), abdominal circumference (AC), and femur length (FL). The physicians rating the images were blinded to the agent used to capture each image and had no knowledge of the randomization list created by the study statisticians. The image quality scores given by the two experienced Maternal-Fetal Medicine physicians were averaged to compute a single score for each image per coupling agent.

Time frame:
ultrasound scanning, an average of 1 hour
Reported as:
Mean · score on a scale
Quality of Ultrasound Images
score on a scaleCoconut Oil QualityCommercial Ultrasound Gel Quality
BPD/HC76.05 ± 3.7576.14 ± 3.75
AC75.18 ± 2.5076.35 ± 2.50
FL78.00 ± 0.8879.13 ± 0.88
SecondaryAcceptability

Patient acceptability of coconut oil as compared to commercial ultrasound gel was assessed using a ten-question acceptability survey measured on a five-point Likert scale which was adapted from a previously validated survey. Higher scores meant a better outcome for questions 1 and 2 and a lower score meant a better outcome for questions 3, 4, and 5. The minimum value was a score of 1 and the maximum value was a score of 5.

Time frame:
after ultrasound scanning, an average of 1 hour
Reported as:
Mean · units on a scale
Acceptability
units on a scaleCoconut Oil Followed by Commercial Ultrasound GelCommercial Ultrasound Gel Followed by Coconut Oil
The gel/coconut oil used in the scan was messy.4.08 ± 42.55 ± 2
I experienced itching/burning/redness from the scan.4.83 ± 54.65 ± 5
The gel/coconut oil was easy to remove/rub in after the scan.4.50 ± 53.48 ± 4
I like how my skin felt after using the gel/coconut oil.4.55 ± 42.70 ± 3
I would have a scan with this gel again.4.68 ± 43.78 ± 4

Adverse events

Collected over ultrasound scanning, an average of 1 hour. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Coconut Oil0/40 (0%)0/40 (0%)0/40 (0%)
Ultrasound Gel0/40 (0%)0/40 (0%)0/40 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Coconut Oil Followed by Commercial Ultrasound GelCommercial Ultrasound Gel Followed by Coconut OilTotal
Sex: Female, Male
Sex: Female, Male(Participants)Coconut Oil Followed by Commercial Ultrasound GelCommercial Ultrasound Gel Followed by Coconut OilTotal
Female202040
Male000
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Coconut Oil Followed by Commercial Ultrasound GelCommercial Ultrasound Gel Followed by Coconut OilTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Coconut Oil Followed by Commercial Ultrasound GelCommercial Ultrasound Gel Followed by Coconut OilTotal
United States202040
08

Study locations

1 site
  • Riley Hospital for Children at IU Health
    Indianapolis, Indiana 46202, United States
09

References and documents

Publications

  • Agero AL, Verallo-Rowell VM. A randomized double-blind controlled trial comparing extra virgin coconut oil with mineral oil as a moisturizer for mild to moderate xerosis. Dermatitis. 2004 Sep;15(3):109-16. doi: 10.2310/6620.2004.04006. PubMed 15724344 ↗
  • DebMandal M, Mandal S. Coconut (Cocos nucifera L.: Arecaceae): in health promotion and disease prevention. Asian Pac J Trop Med. 2011 Mar;4(3):241-7. doi: 10.1016/S1995-7645(11)60078-3. Epub 2011 Apr 12. PubMed 21771462 ↗
  • Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother. 1972 Jul;2(1):23-8. doi: 10.1128/AAC.2.1.23. PubMed 4670656 ↗
  • Esquenazi D, Wigg MD, Miranda MM, Rodrigues HM, Tostes JB, Rozental S, da Silva AJ, Alviano CS. Antimicrobial and antiviral activities of polyphenolics from Cocos nucifera Linn. (Palmae) husk fiber extract. Res Microbiol. 2002 Dec;153(10):647-52. doi: 10.1016/s0923-2508(02)01377-3. PubMed 12558183 ↗

Study documents

  • Protocol and statistical analysis plan · Nov 3, 2021
  • Informed consent form · Oct 26, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05653362
Lead sponsor
Indiana University
Responsible party
Caroline Rouse (Assistant professor of Obstetrics and Gynecology, Indiana University) — Principal investigator
First posted
Dec 16, 2022
Start date
Dec 1, 2021
Primary completion
Dec 22, 2021
Completion
Dec 22, 2021
Results posted
Jun 2, 2023
Last update
Jun 2, 2023

Study contacts

Caroline Rouse, MD
principal investigator · Indiana University Department of Maternal Fetal Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion